Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Roblin

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Alimentary Pharmacology & Therapeutics|June 18, 2015
Letter: stool adalimumab detection in ulcerative colitis and Crohn's diseaseX Roblin, S Paul
The American Journal of Gastroenterology|March 7, 2015
Response to Bodini et alS Paul, X Roblin
Diseases of the Colon and Rectum|February 5, 2005
Is cytomegalovirus really a cause of resistance to steroids in ulcerative colitis?X Roblin, B Bonaz
La Revue De Medecine Interne|December 6, 2003
[Hepatitis related to amoxicillin or levofloxacin: a case report]F Heluwaert, X Roblin, V Duffournet, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Acute pancreatitis induced by gliclazide]X Roblin, Y Abinader, A Baziz
The American Journal of Gastroenterology|May 6, 2015
Kinetics of Antibodies Against Adalimumab Are Not Associated With Poor Outcomes in IBDS Paul, W Dronne, X Roblin
La Revue De Medecine Interne|January 1, 1994
[Value of biliary tubage in the diagnosis of acute pancreatitis without recognized etiology]X Roblin, J Blais, F André
The American Journal of Gastroenterology|March 9, 2017
Response to Zidar and TepesS Pillet, B Pozzetto, X Roblin
Clinics and Research in Hepatology and Gastroenterology|November 1, 2025
Associations of advanced therapies in inflammatory bowel diseasesM Uzzan, M Barrau, X Roblin
Alimentary Pharmacology & Therapeutics|September 3, 2015
Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel diseaseS Paul, X Roblin, L Peyrin-Biroulet
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Alimentary Pharmacology & Therapeutics|June 18, 2015
Letter: stool adalimumab detection in ulcerative colitis and Crohn's diseaseX Roblin, S Paul
The American Journal of Gastroenterology|March 7, 2015
Response to Bodini et alS Paul, X Roblin
Diseases of the Colon and Rectum|February 5, 2005
Is cytomegalovirus really a cause of resistance to steroids in ulcerative colitis?X Roblin, B Bonaz
La Revue De Medecine Interne|December 6, 2003
[Hepatitis related to amoxicillin or levofloxacin: a case report]F Heluwaert, X Roblin, V Duffournet, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Acute pancreatitis induced by gliclazide]X Roblin, Y Abinader, A Baziz
The American Journal of Gastroenterology|May 6, 2015
Kinetics of Antibodies Against Adalimumab Are Not Associated With Poor Outcomes in IBDS Paul, W Dronne, X Roblin
La Revue De Medecine Interne|January 1, 1994
[Value of biliary tubage in the diagnosis of acute pancreatitis without recognized etiology]X Roblin, J Blais, F André
The American Journal of Gastroenterology|March 9, 2017
Response to Zidar and TepesS Pillet, B Pozzetto, X Roblin
Clinics and Research in Hepatology and Gastroenterology|November 1, 2025
Associations of advanced therapies in inflammatory bowel diseasesM Uzzan, M Barrau, X Roblin
Alimentary Pharmacology & Therapeutics|September 3, 2015
Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel diseaseS Paul, X Roblin, L Peyrin-Biroulet
Pageof 9